Table 3:
Parameters | HC (n=20) | INPH (n=16) | AD (n=10) | SVaD (n=10) | ANOVA, F or H Value |
---|---|---|---|---|---|
Anterior PVWM | |||||
FA | 0.53 (0.02) | 0.54 (0.03)b | 0.54 (0.02) | 0.49 (0.03) | 8.83c |
MD | 0.50 (0.02) | 0.55 (0.03)b,d,e | 0.52 (0.02) | 0.61 (0.03) | 40.15c |
Posterior PVWM | |||||
FAf | 0.55 (0.54–0.55) | 0.57 (0.56–0.57)b,d | 0.56 (0.55–0.56) | 0.51 (0.50–0.53) | 24.58c |
MD | 0.53 (0.02) | 0.55 (0.03)b | 0.53 (0.02) | 0.61 (0.03) | 25.20c |
aIC | |||||
FA | 0.55 (0.02) | 0.59 (0.04)b,d | 0.57 (0.03) | 0.50 (0.04) | 16.64c |
MD | 0.49 (0.02) | 0.53 (0.04)b,d,e | 0.50 (0.03) | 0.60 (0.04) | 33.32c |
pIC | |||||
FA | 0.59 (0.02) | 0.63 (0.03)b,d,e | 0.60 (0.02) | 0.57 (0.02) | 18.67c |
MDf | 0.48 (0.47–0.48) | 0.50 (0.49–0.52)d | 0.48 (0.47–0.49) | 0.56 (0.54–0.57) | 31.03c |
Genu, CC | |||||
FAf | 0.70 (0.64–0.71) | 0.66 (0.60–0.70) | 0.66 (0.64–0.70) | 0.64 (0.62–0.67) | 5.45 |
MDf | 0.58 (0.55–0.61) | 0.67 (0.63–0.75)d | 0.62 (0.67–0.65) | 0.69 (0.61–0.75) | 20.67g |
Splenium, CC | |||||
FAf | 0.64 (0.62–0.66) | 0.64 (0.60–0.68)b | 0.66 (0.63–0.68) | 0.56 (0.52–0.63) | 11.59g |
MD | 0.85 (0.17) | 0.82 (0.14)b | 0.88 (0.12) | 1.03 (0.16) | 4.26g |
SLF | |||||
FA | 0.47 (0.02) | 0.50 (0.03)b,d | 0.48 (0.02) | 0.44 (0.03) | 11.86c |
MD | 0.48 (0.02) | 0.51 (0.02)b,d,e | 0.49 (0.02) | 0.56 (0.02) | 36.00c |
ILF | |||||
FA | 0.49 (0.02) | 0.47 (0.03)d | 0.49 (0.03) | 0.46 (0.02) | 4.72g |
MDf | 0.57 (0.55–0.65) | 0.57 (0.54–0.62)b | 0.59 (0.57–0.64) | 0.64 (0.60–0.67) | 7.85g |
Variables are mean (±SD) or median (interquartile range).
P < .05, compared with the SVaD group.
P < .001.
P < .05, compared with the HC group.
P < .05, compared with the AD group.
The Dunn method was used to correct multiple comparisons. In other cases, the Holm-Sidak method was used.
P < .05.